Most cases of lower urinary tract symptoms due to benign prostatic hyperplasia are initially managed through medical therapy. In cases that surgery is indicated, the anatomical endoscopic enucleation of the prostate (aEEP), first described in 1983, allegedly presents the same safety profile as the best endoscopic non-enucleating procedures and the same long-term functional outcomes as […]
To evaluate the expression of urinary biomarkers of inflammation and tissue remodeling in patients with BPH undergoing surgery and evaluate the association of biomarkers with postoperative urodynamic outcomes MATERIALS AND METHODS: We analyzed urine samples from 71 patients treated with TURP from 2011 to 2017.
We present the case of a 24-year-old male who underwent a laparoscopic left retroperitoneal lymph node dissection for lymph node metastasis detected at the staging CT-scan after a radical left orchifuniculectomy for a non seminomatous testicular tumor (pT2, Stage IIB).
Erectile dysfunction incidence is about 19-26 cases for every 1000 men/year, requiring about 20,000 penile implants/year. There is high demand for information on the part of patients, however, there is a lack of evidence about the sources of information prior to penile implant and the figure of the Expert Patient (EP) has never been described […]
Retrospective, cross-sectional. To determine the capacity of the ice water test (IWT) to predict erectile function during the early phase of spinal cord injury (SCI). France. This was a retrospective, cross-sectional study.
The effect of erectile dysfunction (ED) on sexual planning behaviors and outcomes in men taking phosphodiesterase type 5 inhibitors (PDE5Is) is not well studied. To assess sexual habits, behaviors, and treatment-related outcomes of PDE5I-treated men with ED.
Charles Ryan: Hello, and welcome to a round table discussion on DNA repair and PARP inhibitor therapy in prostate cancer. I’m Chuck Ryan. I’m a Professor of Medicine, a medical oncologist, and I’m at the University of Minnesota in Minneapolis. And, I’m delighted to be joined by Dr. Veda Giri, who’s an Associate Professor at […]
Ashish Kamat: Welcome to UroToday’s Bladder Cancer Center of Excellence. I’m Ashish Kamat from MD Anderson Cancer Center in Houston, Texas. And it’s my distinct pleasure to be joined by Dr. Seth Lerner, who is Professor of Urology and the Beth and Dave Swalm Chair in Urologic Oncology at the Scott Department of Urology at […]
Alicia Morgans: Hi, my name is Alicia Morgans and I’m a GU medical oncologist at Northwestern University, also, an Associate Professor there. I am so excited to have here with me today, two speakers who presented on personalized approaches to the treatment of prostate cancer and how they impact our decisions now and will in […]
Introduction: Steinstrasse or ‘Stone Street’ is an accumulation of stone fragments or gravel in the ureter which may cause a downstream obstruction to urine flow.1 It constitutes a potentially serious complication of treatment of large renal calculi, by surgery or use of extracorporeal shockwave lithotripsy (SWL). Steinstrasse occurs in 4-7% of patients treated with SWL.2 Stone […]
